Video

Dr. Secord on Understanding Patient Preferences

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses the importance of understanding patient preferences regarding treatment regimens.

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses the importance of understanding patient preferences regarding treatment regimens.

If practitioners do not understand their patients’ goals for therapy, then they may not be delivering patients the best regimen, Secord says. While some patients deem survival the most important factor of their therapy, others may place quality of life higher on the list. Therefore, practitioners could possibly provide patients with a more toxic regimen that does not improve their survival in a clinically meaningful way, if they do not take their preferences into account.

What a physician thinks is an overly toxic regimen may not be the equivalent of what a patient believes is overly toxic, Secord explains. For example, one patient may be willing to accept severe toxicity in order to obtain additional time of living longer without disease, while some patients may not be able to tolerate any amount of toxicity.

As an example, Secord describes a patient who is an artist and soccer player with a preference to avoid therapy with neurotoxicity, since it will dramatically affect her livelihood and regular activities.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center